Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03055403Phase 1Completed
Phase 1, randomised, double-blind trial comparing M201-A Injection with Placebo (2 arms). Primary endpoint: Number of participants with adverse events. Started Feb 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03055403.